Zhaoke Ophthalmology Ltd 2023 SR
The report highlights Zhaoke Ophthalmology's progress in 2023, focusing on its transition to commercialization with the mass production of ophthalmic drugs. Key environmental initiatives include the planned 2024 launch of a distributed photovoltaic power generation project at its Guangzhou facility to reduce carbon emissions. Socially, the company maintained a zero-fatality record and achieved a 100% employee training rate. The group also established a business compliant committee to enhance governance and anti-corruption efforts.
Company: Zhaoke Ophthalmology Ltd
Sector: Health Care
Country: China
Year: 2023
Type: SR
Pages: 56
Zhaoke Ophthalmology Ltd
ESG Report
The report highlights Zhaoke Ophthalmology's progress in 2023, focusing on its transition to commercialization with the mass production of ophthalmic drugs. Key environmental initiatives include the planned 2024 launch of a distributed photovoltaic power generation project at its Guangzhou facility to reduce carbon emissions. Socially, the company maintained a zero-fatality record and achieved a 100% employee training rate. The group also established a business compliant committee to enhance governance and anti-corruption efforts.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English, Chinese
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees